OP0249 Multi-Biomarker Disease Activity and Autoantibody Status Lead to Cost Effective Tapering Algorithms in Rheumatoid Arthritis Patients in Sustained Remission

doi 10.1136/annrheumdis-2017-eular.2988
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ Publishing Group Ltd and European League Against Rheumatism

Related search

Adalimumab Discontinuation in Patients With Rheumatoid Arthritis After Achieving Sustained Remission

Nauchno-Prakticheskaya Revmatologiya
RheumatologyAllergyImmunology
2018English

Patient’s Perspective of Sustained Remission in Rheumatoid Arthritis

BMC Musculoskeletal Disorders
RheumatologyOrthopedicsSports Medicine
2017English

Sex Differences in the Achievement of Remission and Low Disease Activity in Rheumatoid Arthritis

Arthritis Care and Research
Rheumatology
2020English

FRI0244 Low Dose of Rituximab Is Effective for Maintenance of Clinical Remission or Low Disease Activity in Patients With Rheumatoid Arthritis

2017English

Mental Health Status Can Reflect Disease Activity in Rheumatoid Arthritis

European Journal of Rheumatology
2014English

SAT0061 Haq Score Is an Independent Predictor of Sustained Remission in Patients With Rheumatoid Arthritis

2017English

OP0289 Treat-To-Target in Early Rheumatoid Arthritis: Association Between Sustained Remission and Joint Damage

2017English

Neutrophil-Lymphocyte Ratio, Pain Perception, and Disease Activity Score May Serve as Important Predictive Markers for Sustained Remission in Rheumatoid Arthritis

Reumatismo
Rheumatology
2016English

Disease Activity (Rheumatoid Arthritis Disease Activity Index-5) in Patients With Rheumatoid Arthritis and Its Association With Quality of Life, Pain, Fatigue, and Functional and Psychological Status

Archives of Rheumatology
Rheumatology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy